As a patient of the Allegheny Health Network Cancer Institute, you receive care from expert physicians who use the most innovative approaches to treat liver cancer. We are one of a select group of medical institutions in the country to have a program devoted solely to treating patients with liver cancer. This includes those with primary liver tumors and those with disease that has metastasized to the liver from other parts of the body.
Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver.
Blue Faery\'s mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma (HCC), through research, education and advocacy.
Blue Faery was founded in honor of 15-year-old Adrienne Wilson, who lost her battle with HCC after only 147 days. Read Adrienne\'s Story.
Welcome! If you are new to our Website or the new design I hope that your experience will be a productive one. The purpose of this introduction is to acquaint you with some of the features of the website.
If you are looking for specific information, you may want to start at the Google search engine located at the right of the page (bottom of the page on mobile and tablets).
Help‑4‑Hep is a non-profit, peer-to-peer helpline where counselors work with patients to meet the challenges of hepatitis C head-on. Callers talk one-to-one with a real person, typically someone who\\\'s had hepatitis C touch their own life. And they talk about the specifics of their particular situation. The phone call, support and information are all provided free of charge.
HCV Treatment Access
The NVHR supports the position that all people living with hepatitis C deserve lifesaving treatment, and calls for immediate action for significantly expanded access to address the largest blood borne viral epidemic in the United States.
To Prevent and Cure Liver Disease
To advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care
AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD was founded in 1950 by a small group of leading liver specialists (including Hans Popper, Leon Schiff, Fred Hoffbauer, Cecil Watson, Jesse Bollman, and Sheila Sherlock, to name a few) to bring together those who had contributed to the field of hepatology.
- See more at: http://www.aasld.org/about-aasld#sthash.TLNN7Ywz.dpuf
Co-infection with hepatitis among people with HIV is emerging as a growing problem. For people infected with HIV through needle exposure probably due to drug use, 40% or more may also have hepatitis C. The NATAP Hepatitis Section was started to raise awareness about this problem, and to provide basic education and more advanced scientific information.
When you or someone you love is Living with Hepatitis C, you need as much reliable information as you can find. HepatitisCentral.com is here to help educate patients and their families about hepatitis, its symptoms and all the available treatment options. With our editors continuously scanning press releases, news reports and clinical trial results, this is where you\'ll first learn about breakthrough treatments and critical information on related conditions such as ascites, elevated liver enzymes and autoimmune hepatitis.
Welcome. The Hepatitis Foundation International (HFI) is a 501 (c) 3 non-profit organization established in 1994 working to eradicate chronic hepatitis for 400 million people globally. HFI is also dedicated to increasing and promoting health and wellness, as well as, reducing the incidence of preventable liver-related chronic diseases and lifestyles that negatively impact the liver.
Hepatitis is the term used for a liver that is inflamed. Inflammation is the local reaction of the body to a variety of damaging agents. The inflammation is the consequence of the damaging effect to for example liver cells that may be killed and the response of the body that may react more or less outspoken. A powerful reaction may be very helpful to kill a damaging virus. A too strong reaction may cause such severe damage that the outcome could be lethal. A too weak reaction may lead to failure of the body to eradicate the virus and therefore the infection become chronic with variable damage.
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention maximizes public health and safety nationally and internationally through the elimination, prevention, and control of disease, disability, and death caused by HIV/AIDS, viral hepatitis, STDs and TB.
The mission of Hep C Connection is to educate the general public about hepatitis C and to provide resources and support for those affected by the virus.
Have an informed, de-stigmatized understanding of the hepatitis C virus (HCV)
Know how to avoid contracting HCV
Have access to education, resources, screening, and support in dealing with the disease
Have the knowledge to make intelligent personal decisions about HCV treatment
What is Hepatitis C?
Hepatitis C is a blood-borne, infectious disease of the liver`, which can lead to serious liver problems, including cirrhosis (scarring of the liver) and liver cancer. Hepatitis C virus (HCV) is the leading cause of liver transplants in the United States.1
This site is dedicated to providing up-to-date information on hepatitis C, HIV, and HCV/HIV co-infection as it relates to federal and state lobbying efforts and HIV and HCV public policies and funding programs. Moreover to specifically address the issues of those disproportionately affected by the epidemic, namely intravenous drug users and the substance using community at large. The site was initiated by and designed for advocates, service providers, and HIV/HCV co-infected consumers.